Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

Clinical trial NCT01310894 · COMPLETED

Trial details

NCT number: NCT01310894
Sponsor: Steba Biotech S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-02-01
Primary completion: 2015-06-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.